Sam is a trader and one of our lead stock analysts at AskTraders. After starting his career predominantly in the forex markets, Sam now focuses on gold and stocks with a preference for macroeconomic analysis.
Moderna (NASDAQ: MRNA) has announced that the Philippines has secured 7 million additional doses of its Covid-19 vaccine through a new supply agreement.
The new agreement brings the confirmed order commitment up to 20 million doses for the country following its initial procurement of 13 million at the beginning of March.
The 7 million additional doses were secured via a partnership with the private sector, Moderna said. Deliveries are expected to begin in mid-2021.
However, the vaccine is currently not approved for use in the country, although the company said they will work with regulators to pursue the necessary approvals before its distribution.
“We appreciate the continued confidence demonstrated by the government of the Philippines through this new agreement, as well as the support of the private sector, resulting in 20 million doses secured for the country,” said Stéphane Bancel, Chief Executive Officer of Moderna.
Moderna’s share price is trading 1.5% higher on Monday at $145.88.
Should you invest in Moderna shares? One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now…
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .